Floaters May Signal Higher Risk Than Flashes

• by Conexiant News Staff

• March 24, 2026

FDA Approves Auvelity for Agitation in Alzheimer’s Disease

The oral combination therapy expands treatment options for agitation associated with dementia due to Alzheimer’s disease.

• by Kathryn Wighton

• April 30, 2026

• 3 min

AAP Updates Pediatric Office Emergency Readiness

Guidance addresses office readiness, recommended equipment and medications, and team communication processes for infrequent but high-acuity emergencies.

• by Kathryn Wighton

• May 5, 2026

• 5 min

Matrix and graphical representation of the primary headache syndromes in the International Classification of Headache Disorders (ICHD3): a basis for automated diagnosis and analysis of criteria

• by Pengfei Zhang, Roger Cheng

• May 11, 2026